Control Release of Paclitexel-Coated 316L Cardiovascular Stent In Vitro


Article Preview

Now the Cardio vascular restenosis in the clinic is still an unsolved question. The fact is that, if the 316L stent is without coating, it will harm the blood vessel wall and the inflammatory reaction of eye winker. This research is about the Paclitexel-drug coating stent that can be adapted to avoid restenosis. The drug control released by different methods, and also the nano-material releasing after the coating formation are investigated.



Key Engineering Materials (Volumes 288-289)

Edited by:

Xingdong Zhang, Junzo Tanaka, Yaoting Yu and Yasuhiko Tabata




H. Dong et al., "Control Release of Paclitexel-Coated 316L Cardiovascular Stent In Vitro", Key Engineering Materials, Vols. 288-289, pp. 583-586, 2005

Online since:

June 2005




[1] Qian Jie, Gao Mingwei, Gene research about albumen coated stent used incoronary artery of little pigs, China Cycle Magazine, Vol. 14, No. 3, 1999. 6.

[2] Li Manxiang, Cui Changzong, Lan Yanping, Wang Dongqi, Bo Wen, Research of Implanting domestic made paclitaxel-eluting stent into incoronary artery of dog, Xi'an Medical University Transactions, Vol. 21, No. 3, 2000. 6.

[3] Yuan Jinqing, Gao Runlin, The influence of coronary artery restenosis for coated stent , China Cardiovascular Disease Magazine, Vol. 27, No. 5, 1999. 10.

[4] Huang Zuo, Zhao Jun, Wu Zonggui, The progress of restenosis within coronary artery stent, 2nd Military Medical University Trans., V. 22, No. 5, 1999. 2.

[5] Nie Xiaomin, The selects and applications actuality of membrane wrapping stent. China Practical Medicine Magazine, Vol. 22, No. 4, 2002. 4.

[6] Qiao Shubin, Gao Runlin, Implantation care in cardiovascular hospitals in other cities 1999, China Cycle Magazine, Vol. 15, No. 5, 2000. 10.

[7] Huang Zhenhua, Implanting stents within incoronary artery, Foreign Iatrology Medicine Fascicule, Vol. 27, No. 3, (2000).